New drugs for the treatment of diabetes mellitus - Part I: Thiazolidinediones and their evolving cardiovascular implications

被引：90
|
作者：
McGuire, Darren K. [1 ,2 ]
Inzucchi, Silvio E. [3 ]
机构：
[1] Univ Texas Dallas, SW Med Ctr, Div Cardiol, Dallas, TX 75235 USA
[2] Univ Texas Dallas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75235 USA
[3] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA
来源：
CIRCULATION | 2008年 / 117卷 / 03期
关键词：
cardiovascular diseases; diabetes mellitus; drugs; glucose; thiazolidinediones;
D O I：
10.1161/CIRCULATIONAHA.107.704080
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：440 / 449
页数：10
相关论文
共 50 条
  • [1] Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
    Füchtenbusch, M
    Standl, E
    Schatz, H
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (03) : 151 - 163
  • [2] Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2
    Yandrapalli, Srikanth
    Malik, Aaqib
    Horblitt, Adam
    Pemmasani, Gayatri
    Aronow, Wilbert S.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2020, 28 (05) : 219 - 235
  • [3] Cardiovascular Safety Evaluation in the Development of New Drugs for Diabetes Mellitus
    Menon, Venu
    Lincoff, A. Michael
    CIRCULATION, 2014, 129 (25) : 2705 - 2713
  • [4] Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus-Part 1
    Yandrapalli, Srikanth
    Jolly, George
    Horblitt, Adam
    Pemmasani, Gayatri
    Sanaani, Abdallah
    Aronow, Wilbert S.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2020, 28 (04) : 177 - 189
  • [5] Thiazolidinediones in patients with diabetes mellitus and heart failure: Implications of emerging data
    Macfarlane D.P.
    Fisher M.
    American Journal of Cardiovascular Drugs, 2006, 6 (5) : 297 - 304
  • [6] Cardiovascular Implications of Hypoglycemia in Diabetes Mellitus
    Connelly, Kim A.
    Yan, Andrew T.
    Leiter, Lawrence A.
    Bhatt, Deepak L.
    Verma, Subodh
    CIRCULATION, 2015, 132 (24) : 2345 - 2350
  • [7] Effects of thiazolidinediones for early treatment of type 2 diabetes mellitus
    Kudzma, DJ
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (16): : S472 - S482
  • [8] Thiazolidinediones and type 2 diabetes: new drugs for an old disease
    O'Moore-Sullivan, TM
    Prins, JB
    MEDICAL JOURNAL OF AUSTRALIA, 2002, 176 (08) : 381 - 386
  • [9] Clinical outcomes trials and the cardiovascular effects of thiazolidinediones: Implications for the evaluation of antidiabetic drugs
    Gerstein, Hertzel C.
    Yusuf, Salim
    AMERICAN HEART JOURNAL, 2010, 160 (01) : 1 - 2
  • [10] Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion
    Zannad, Faiez
    Stough, Wendy Gattis
    Lipicky, Raymond J.
    Tamargo, Juan
    Bakris, George L.
    Borer, Jeffrey S.
    Garcia, Maria de los Angeles Alonso
    Hadjadj, Samy
    Koenig, Wolfgang
    Kupfer, Stuart
    McCullough, Peter A.
    Mosenzon, Ofri
    Pocock, Stuart
    Scheen, Andre J.
    Sourij, Harald
    Van der Schueren, Bart
    Stahre, Christina
    White, William B.
    Calvo, Gonzalo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (03) : 200 - 205
12345